At NorthX Biologics, we are more than a Contract Development and Manufacturing Organization (CDMO), we are true partners in innovation. Our expertise within bioprocessing spans a variety of advanced modalities, including recombinant proteins, viral vaccines and cell therapy, supporting clients from concept through to commercial manufacturing.

Operating two facilities with state-of-the-art microbial and mammalian capabilities, we have been manufacturing biologics to GMP since 1992. In 2021, NorthX Biologics was recognized by the Swedish government as a national competence center for advanced biologics and gene therapies. This recognition empowered us to expand our mission and develop the concept we call “Beyond CDMO”.

Beyond CDMO is our way of working; we succeed when our clients and partners thrive.